Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
16,872,606
-
Share change
-
-429,784
-
Total reported value
-
$191,194,968
-
Price per share
-
$11.34
-
Number of holders
-
79
-
Value change
-
-$4,958,105
-
Number of buys
-
20
-
Number of sells
-
35
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q2 2016
As of 30 Jun 2016,
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,872,606 shares.
The largest 10 holders included
Boston Partners, Paradice Investment Management LLC, JANUS CAPITAL MANAGEMENT LLC, HEARTLAND ADVISORS INC, ACK Asset Management LLC, Park West Asset Management LLC, ROYCE & ASSOCIATES LP, BANK OF MONTREAL /CAN/, Lapides Asset Management, LLC, and Senvest Management, LLC.
This page lists
79
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.